Table 2.
Number | % | Age (years) |
|||
---|---|---|---|---|---|
Mean | Range | ||||
Antibiotic use in last 30 days | |||||
Yes | 89 | 84.8 | 35.1 | (3–86) | |
No | 16 | 15.2 | 37.9 | (13–61) | |
Antibiotic class | Generic name | ||||
Unreported antibiotic | 16 | 15.2 | 37.9 | (13–61) | |
Penicillins | |||||
Amoxicillin | 31 | 29.5 | 36.8 | (5–86) | |
Nitroimidazoles | Ampicillin | 2 | 1.9 | 34.5 | (29–40) |
Cephalosporins | Metronidazole | 20 | 19.1 | 31.4 | (3–58) |
Cephalosporin | 10 | 9.5 | 31.5 | (19–60) | |
Cephalexin | 1 | 1 | 35 | – | |
Fluoroquinolones | Ceftriaxone | 9 | 8.6 | 34.3 | (17–61) |
Ciprofloxacin | 6 | 5.7 | 31.8 | (18–42) | |
Macrolides | Levofloxacin | 2 | 1.9 | 56.5 | (56–57) |
Sulfonamides | Azithromycin | 4 | 3.8 | 31 | (22–39) |
Glycopeptides | TMP–SMX | 2 | 1.9 | 45.5 | (43–48) |
Vancomycin | 1 | 1 | 71 | – |
TMP–SMX, trimethroprim–sulfamethoxazole.